Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

Biliary Tract Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Carcinoma, Non-Small-Cell Lung

EGFR Positive Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Relapsed Pediatric Solid Tumor

Diffuse Intrinsic Pontine Glioma

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Lung Diseases, Neoplasms, Respiratory Tract Diseases, Thoracic Neoplasms

Metastatic Pancreatic Adenocarcinoma

Drug-Related Side Effects and Adverse Reactions

Breast Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Advanced Stage Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Pancreatic Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Erlotinib Combined With Chemotherapy in TKI Resistant Non-Small Cell Lung Cancers

ROME

Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

ERLO-XIB

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

AvaTa

Efficacy and Safety of Precision Therapy in Refractory Tumor

ANSWER

Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

BIOMEDE

BRILLIANT

Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC

ML22774

High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs

Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer

Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation

RT Plus EGFR-TKI for Wild-type NSCLC

Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma

Safety and Effectiveness Study of Chemotherapy in Combination With Erlotinib,or Sequential Erlotinib for Treatment in Patients With NSCLC

Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer

NSCLC EGFR TKI

Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)

The Role of EGFR Mutations in Pancreatic Cancer Patients Receiving Gemcitabine With or Without Erlotinib

TRACTS

A Phase II Study to Assess Efficacy of Combined Treatment With Erlotinib (Tarceva) and Silybin-phytosome (Siliphos) in Patients With EGFR Mutant Lung Adenocarcinoma

Intermittent and Maintenance of Erlotinib in Combination With Pemetrexed/Carboplatin in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Oncology

Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme

Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

ROLE

Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations

Induction Chemotherapy Followed by CCRT According to EGFR Mutation Status in NSCLC III

Dux

A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations

The Continuation of Erlotinib

RT0901

ERLOPET

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

TIE

Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer

Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene